Maternal serum inhibin A can predict pre-eclampsia

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 105, Issue 10, 1998, Pages 1101-1103

  Cuckle, Howard ^a   Sehmi, Indera ^a   Jones, Richard ^b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INHIBIN A;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; PREECLAMPSIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SECOND TRIMESTER PREGNANCY;

BIOLOGICAL MARKERS; FEMALE; HUMANS; INHIBINS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PRENATAL DIAGNOSIS; RETROSPECTIVE STUDIES;

EID: 0031705738     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1998.tb09943.x     Document Type: Article

References (12)

1. Roberts JM, Redman CWG. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 1993; 341:1447–1451.
2. Redman CWG. Hypertension in pregnancy. In Chamberlain, G, editor. Turnbull’s Ohstetrics. London : Churchill Livingstone, 1995: 441–470.
3. Muttukrishna S, Knight PG, Groome NP, Redman CWG, Ledger WL. Activin A and inhibin A as possible endocrine markers of pre-eclampsia. Lancet 1997; 349: 1285–1288.
4. Cuckle HS, Holding S, Jones R, Groom NP, Wallace EM. Combining inhibin A with existing second-trimester markers in maternal serum screening for Down’s syndrome. Prenat Diagn 1996; 16: 1095–1100.
5. Levene RJ, Hauth JC, Curet LB et al. Trial of calcium to prevent preeclampsia. N Engl J Med 1997; 337: 69–76.
6. CLASP Collaborative Group. CLASP: a randomised trial of low-dose aspirin for the prevention of preeclampsia among 9364 pregnant women. Lancet 1994; 343: 619–629.
7. Wald NJ, Watt HC. Serum markers for Down’s syndrome in relation to number of previous births and maternal age. Prenat Diagn 1996; 16699–703.
8. Sibai BM, Ewell M, Levine RJ, Klebanoff MA, Esterlitz J, Catalano PM, Goldenberg RL, Joffe G. Risk factors associated with preeclampsia in healthy nulliparous women. Am J Obstet Gynecol 1997; 177: 1003–1010.
9. Muller F, Savey L, Le Fiblec B et al. Maternal serum human chorionic gonadotropin level at fifteen weeks is a predictor for ere-eclampsia. Am J Obstet Gynecol 1996; 175: 3740.
10. Friedman-SA, Schiff E, Emeis JJ, Dekker GA, Sibai BM. Biochemical corroboration of endothelial involvement in severe preeclampsia. Am J Ohstet Gynecul 1995; 172:202–203.
11. Padriberg KM, DeJong CLD, Van Geijn HP, Van Kamp GJ. Heinen AGJJ, Dekker GA. Total plasma fibronectin as a marker of pregnancy-induced hypertensive disorders: a longitudinal study. Obstet Gynecul 1998; 91: 383–388.
12. Petraglia F, Aguzolli L, Gallinelli A et al. Hypertension in pregnancy: changes in activin A maternal serum concentration. Placenta 1995: 16: 447–454.